These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

533 related items for PubMed ID: 8464986

  • 1. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA, Koblar S, Hughes RA.
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
    Oomes PG, Jacobs BC, Hazenberg MP, Bänffer JR, van der Meché FG.
    Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
    [Abstract] [Full Text] [Related]

  • 4. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection.
    Rees JH, Gregson NA, Hughes RA.
    Ann Neurol; 1995 Nov; 38(5):809-16. PubMed ID: 7486873
    [Abstract] [Full Text] [Related]

  • 5. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
    Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL.
    Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
    [Abstract] [Full Text] [Related]

  • 6. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C, Vial C, Petiot P, Bancel J, Later R, Gonnaud PM.
    Ann Biol Clin (Paris); 1999 Aug; 57(5):579-88. PubMed ID: 10518060
    [Abstract] [Full Text] [Related]

  • 7. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
    Tang J, Yuan J, Hao H.
    Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
    [Abstract] [Full Text] [Related]

  • 8. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
    Schessl J, Koga M, Funakoshi K, Kirschner J, Muellges W, Weishaupt A, Gold R, Korinthenberg R.
    Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
    [Abstract] [Full Text] [Related]

  • 9. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y, Matsumoto Y, Yuki N.
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [Abstract] [Full Text] [Related]

  • 10. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
    Jacobs BC, van Doorn PA, Schmitz PI, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkass H, van der Meché FG.
    Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
    [Abstract] [Full Text] [Related]

  • 11. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.
    Kusunoki S, Morita D, Ohminami S, Hitoshi S, Kanazawa I.
    Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116
    [Abstract] [Full Text] [Related]

  • 12. Anti-ganglioside antibodies in peripheral neuropathy.
    McCombe PA, Wilson R, Prentice RL.
    Clin Exp Neurol; 1992 Mar; 29():182-8. PubMed ID: 1343861
    [Abstract] [Full Text] [Related]

  • 13. N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome.
    Odaka M, Yuki N, Yoshino H, Kasama T, Handa S, Irie F, Hirabayashi Y, Suzuki A, Hirata K.
    Ann Neurol; 1998 Jun; 43(6):829-34. PubMed ID: 9629854
    [Abstract] [Full Text] [Related]

  • 14. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
    Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, Yamada M.
    Proc Natl Acad Sci U S A; 2004 Aug 03; 101(31):11404-9. PubMed ID: 15277677
    [Abstract] [Full Text] [Related]

  • 15. [Antiganglioside antibodies: when, which and for what].
    Gallardo E, Rojas-García R, Belvís R, Serrano-Munuera C, Ortiz E, Ortiz N, Grau J, Illa I.
    Neurologia; 2001 Aug 03; 16(7):293-7. PubMed ID: 11485721
    [Abstract] [Full Text] [Related]

  • 16. [An acute axonal form of Guillain-Barré syndrome with antibodies against gangliosides GM1 and GD1b--a case report].
    Yuki N, Yoshino H, Sato S, Ohno T, Miyatake T.
    Rinsho Shinkeigaku; 1990 Sep 03; 30(9):989-93. PubMed ID: 2265511
    [Abstract] [Full Text] [Related]

  • 17. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
    Ogawa G, Kaida K, Kusunoki S, Ueda M, Kimura F, Kamakura K.
    J Neuroimmunol; 2009 Sep 29; 214(1-2):125-7. PubMed ID: 19631994
    [Abstract] [Full Text] [Related]

  • 18. GM 1 antibodies in Guillain-Barré syndrome: isotypes, course and clinical outcome.
    Seiser A, Pötzl G, Safoschnik G, Pichler S, Bernheimer H, Schwerer B.
    Wien Klin Wochenschr; 1994 Sep 29; 106(6):159-63. PubMed ID: 8197746
    [Abstract] [Full Text] [Related]

  • 19. [Guillain-Barre syndrome and antibodies to ganglioside GM1. Case report].
    Trisković I, Dimitrijević Lj, Rakocević-Stojanović V, Trikić R, Apostolski S.
    Srp Arh Celok Lek; 1996 Sep 29; 124(7-8):210-3. PubMed ID: 9102850
    [Abstract] [Full Text] [Related]

  • 20. Anti-ganglioside complex antibodies associated with severe disability in GBS.
    Kaida K, Morita D, Kanzaki M, Kamakura K, Motoyoshi K, Hirakawa M, Kusunoki S.
    J Neuroimmunol; 2007 Jan 29; 182(1-2):212-8. PubMed ID: 17113161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.